Using coding and non-coding rare variants to target candidate genes in patients with severe tinnitus

Alvaro Gallego-Martinez1,2,3, Alba Escalera-Balsera4,5,6, Natalia Trpchevska7

  • 1Otology & Neurotology Group CTS495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Avenida de la Ilustración, 114, 18016, Granada, Spain. alvaro.gallego@genyo.es.

NPJ Genomic Medicine
|November 30, 2022
PubMed